Skip to main content
Clinical Trials/NCT06063408
NCT06063408CompletedNot Applicable

The Effectiveness of Cognitive Functional Therapy in Adults With Chronic Neck Pain: A Pragmatic Randomized Controlled Trial

European University Cyprus1 site in 1 country60 target enrollmentStarted: September 15, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
60
Locations
1
Primary Endpoint
Numerical rating scale

Study Overview

Brief Summary

The aim of this study was to compare the effectiveness of Cognitive Functional Therapy compared with Conventional Therapy in treating adults with chronic neck pain

Detailed Description

After being informed about the study and potential risks, all patients giving written informer consent will undergo 1 week screening period to determine eligibility for study entry. At week 0, patients who meet the eligibility criteria will be randomized in a single- blind manner (assessor), in a 1:1 ration to cognitive functional therapy or conventional therapy twice a week for 8 weeks.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 64 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age 18-64
  • •Pain in neck area for more than 3 months
  • •Pain in NPRS more than 20/100
  • •Independently mobile (with or without aids), to be capable of participating in a rehabilitation program twice a week

Exclusion Criteria

  • •Serious psychological pathology
  • •recently surgery on shoulder or neck area (<6 months)
  • •Pain relieving procedures such as injection based therapy (e.g epidurals) and day case procedures (e.g rhizotomy) in the last 3 months
  • •Pregnancy
  • •Rheumatologic/inflammatory disease (e.g. rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis, lupus, scheuermann's disease)
  • •Progressive neurological disease (e.g. multiple sclerosis (MS), parkinson's disease (PD), motor neuron disease (MND)
  • •Unstable cardiac conditions
  • •Red flag disorders like malignancy/cancer, acute traumas like fracture (<6 months ago) or infection, spinal cord compression/cauda equina

Arms & Interventions

Cognitive Functional Therapy

Experimental

Participants will received in this group four main component:

  1. Pain education, cognitive education, explanation about their health condition, self management education
  2. Graded exposure to painful movements or activities
  3. Movement therapy targeted to their functional integration
  4. Lifestyle programme.

Intervention: Cognitive Functional Therapy (Behavioral)

Conventional Therapy

Active Comparator

Participants will received in this group four main component:

  1. Tens therapy
  2. Massage to cervical and shoulder area
  3. Relaxation techniques
  4. Posture exercises
  5. Workplace education

Intervention: Conventional Therapy (Behavioral)

Outcomes

Primary Outcomes

Numerical rating scale

Time Frame: Baseline (after randomization), at 4th week (after 8th session), at 8th week (after 16th session), 3 months (after randomization)

Measured pain intensity with 0 no pain and 100 the worst pain ever.

Neck Disability Index

Time Frame: Baseline (after randomization), at 4th week (after 8th session), at 8th week (after 16th session), 3 months (after randomization)

This questionnaire has been designed to give us information as to how your neck pain has affected your ability to manage in everyday life. 0= no disability 100= severe disability

Secondary Outcomes

  • EurQqol 5(Baseline (after randomization), at 4th week (after 8th session), at 8th week (after 16th session), 3 months (after randomization))
  • Isometric Strength(Baseline (after randomization), at 4th week (after 8th session), at 8th week (after 16th session), 3 months (after randomization))
  • Short Fort 12(Baseline (after randomization), at 4th week (after 8th session), at 8th week (after 16th session), 3 months (after randomization))
  • Range of motion(Baseline (after randomization), at 4th week (after 8th session), at 8th week (after 16th session), 3 months (after randomization))
  • Fear Avoidance Beliefs Questionnaire(Baseline (after randomization), at 4th week (after 8th session), at 8th week (after 16th session), 3 months (after randomization))

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

George Ploutarchou

Principal Investigator

European University Cyprus

Study Sites (1)

Loading locations...

Similar Trials